What does glutathione IV therapy actually do
Revenue in the GLP-1 market is projected to exceed $100 billion annually by 2030
Beneficiaries should review their plan details to understand potential out-of-pocket expenses

NICE-recommended weight management strategies include: Dietary intervention aiming for a 600 kcal/day deficit through reduced portion sizes, limiting energy-dense foods, and increasing fruit and vegetable consumption Physical activity building up to 150300 minutes of moderate-intensity aerobic activity weekly, plus muscle-strengthening activities on at least two days weekly, in line with UK Chief Medical Officers' guidelines [10] Behavioural approaches including self-monitoring, goal-setting, and addressing emotional eating patterns Commercial weight management programmes such as those meeting NICE quality standards (QS127) Very-low-calorie diets in specific circumstances, under clinical supervision and for limited periods For patients with a BMI 30 kg/m (or 27.5 kg/m in those of South Asian, Chinese, or other Asian family origin) who have not achieved adequate weight loss through lifestyle measures alone, pharmacological interventions may be considered

For this new approach to be considered superior, it must demonstrate similar effectiveness in controlling binge eating and associated psychopathology while also achieving clinically meaningful and sustainable weight loss over time